XPO1 and thyroid gland undifferentiated (anaplastic) carcinoma: Nonetheless, we have demonstrated the therapeutic relevance of targeting nuclear export protein XPO1 and Rho GTPase effector PAK4 which has possible implications in overcoming lenvatinib therapy resistance in anaplastic thyroid cancer.